The challenge
Regenerative therapies are advancing rapidly, and clinical interest continues to grow. Yet the path from innovation to responsible use is not always straightforward. The process varies by country. In the US, there's a national baseline, with a growing number of states enacting their own legislation. That's a lot to track alongside a full practice.
